Stock DNA
Pharmaceuticals & Biotechnology
CNY 35,794 Million (Large Cap)
20.00
NA
1.61%
-0.50
12.85%
2.65
Revenue and Profits:
Net Sales:
2,370 Million
(Quarterly Results - Mar 2026)
Net Profit:
429 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-22.67%
0%
-22.67%
6 Months
-18.2%
0%
-18.2%
1 Year
-16.03%
0%
-16.03%
2 Years
-24.74%
0%
-24.74%
3 Years
-8.21%
0%
-8.21%
4 Years
24.58%
0%
24.58%
5 Years
-0.93%
0%
-0.93%
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.30%
EBIT Growth (5y)
-5.76%
EBIT to Interest (avg)
66.81
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.51
Sales to Capital Employed (avg)
0.59
Tax Ratio
6.63%
Dividend Payout Ratio
44.22%
Pledged Shares
0
Institutional Holding
0.07%
ROCE (avg)
28.47%
ROE (avg)
18.30%
Valuation key factors
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
2.88
EV to EBIT
24.80
EV to EBITDA
20.12
EV to Capital Employed
4.80
EV to Sales
4.02
PEG Ratio
NA
Dividend Yield
2.03%
ROCE (Latest)
19.34%
ROE (Latest)
14.14%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Mar 2017
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.07%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
2,370.40
1,410.10
68.10%
Operating Profit (PBDIT) excl Other Income
465.70
6.80
6,748.53%
Interest
0.00
6.00
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
429.20
17.80
2,311.24%
Operating Profit Margin (Excl OI)
196.50%
-54.80%
25.13%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 68.10% vs -25.23% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 2,311.24% vs -93.32% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
7,903.70
7,491.40
5.50%
Operating Profit (PBDIT) excl Other Income
1,453.80
1,662.90
-12.57%
Interest
6.70
21.70
-69.12%
Exceptional Items
16.70
-20.50
181.46%
Consolidate Net Profit
1,484.10
1,804.30
-17.75%
Operating Profit Margin (Excl OI)
144.50%
184.40%
-3.99%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 5.50% vs -5.06% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -17.75% vs -24.08% in Dec 2024
About Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. 
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






